Drugs / Soluble beta-glucan
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00533364 | Jan 2007 → Aug 2009 | breast cancer | Biotec Pharmacon ASA | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Soluble beta-glucan | “SBG (Soluble beta-glucan)” NCT00533364 ↗ |
| Known as | SBG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00533364 ↗ |
| Route | Oral | “Oral administration” NCT00533364 ↗ |